United Therapeutics Corporation (UTHR)

Name: United Therapeutics Corporation (UTHR) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

HEALTHCARE · Wall Street (EE. UU.) · Última actualización: 2026-09-19

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Cifras clave

Capitalización bursátil: $21 billion
Ingresos (ejercicio cerrado en 2025-12-31): $3.2B
Beneficio neto: $1.3B
Margen bruto: 87.9%
Margen neto: 41.9%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Ingresos totales	$3.2B	$3.2B	$2.9B	$2.3B	$1.9B	$1.7B	$1.5B	$1.4B	$1.6B	$1.7B	$1.6B	$1.5B	$1.3B	$1.1B	$916M	$743M	$604M	$370M	$281M	$211M	$160M
Beneficio bruto	$2.7B	$2.8B	$2.6B	$2.1B	$1.8B	$1.6B	$1.4B	$1.3B	$1.4B	$1.6B	$1.5B	$1.4B	$1.2B	$986M	$797M	$654M	$530M	$325M	$251M	$189M	$143M
% de margen bruto	86.2%	87.9%	89.2%	88.9%	92.4%	92.7%	92.7%	91.9%	87.8%	93.9%	95.5%	95.3%	90.2%	88.3%	87.0%	88.0%	87.8%	87.8%	89.3%	89.5%	89.3%
Ingresos operativos (EBIT)	$1.4B	$1.5B	$1.4B	$1.2B	$980M	$556M	$594M	($188M)	$805M	$815M	$1.1B	$699M	$539M	$292M	$422M	$318M	$164M	$26M	($82M)	$6M	$29M
% de margen operativo	44.5%	47.7%	47.9%	50.9%	50.6%	33.0%	40.0%	-13.0%	49.5%	47.2%	66.4%	47.7%	41.8%	26.2%	46.0%	42.8%	27.2%	7.0%	-29.1%	3.0%	18.2%
Ingresos netos	$1.3B	$1.3B	$1.2B	$985M	$727M	$476M	$515M	($104M)	$589M	$418M	$714M	$652M	$340M	$175M	$304M	$218M	$106M	$19M	($43M)	$20M	$74M
% de margen neto	41.5%	41.9%	41.5%	42.3%	37.6%	28.2%	34.7%	-7.2%	36.2%	24.2%	44.6%	44.5%	26.4%	15.6%	33.2%	29.3%	17.5%	5.3%	-15.2%	9.4%	46.3%
EBITDA	—	$1.8B	$1.7B	$1.4B	$1.0B	$737M	$646M	($75M)	$838M	$1.1B	$1.1B	$1.1B	$575M	$324M	$484M	$341M	$185M	$43M	($68M)	$22M	$29M
Beneficio por acción (EPS)	$27.86	$27.86	$24.64	$19.81	$15.00	$10.06	$11.54	$-2.39	$13.39	$9.31	$15.25	$12.72	$6.28	$3.28	$5.71	$3.67	$1.78	$0.35	$-0.93	$0.44	$1.53
Acciones en circulación (M)	—	48M	48M	50M	48M	47M	45M	44M	44M	45M	47M	51M	54M	53M	53M	59M	60M	56M	46M	45M	48M

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de UTHR. /companies/us/UTHR

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.